Tymazoline

DB08803ExperimentalSmall molecule

Tymazoline is a nasal preparation.

Mechanism: Thymazen causes vasoconstriction of the nasal mucosa, reducing congestion and thus the swelling of the mucosa. Also reduces the secretions from the nose. Thymazen acts on alpha-adrenergic receptors, which reduces local inflammation of the nasal mucosa especially if their cause is an allergy.
Curator reviewed
Primary indication: For the treatment of Inflammation of the lining of the nose and paranasal sinuses and allergic inflammation of nasopharyngeal.Curator reviewed
Formula / weight: C₁₄H₂₀N₂O · 232.3214 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyQRORCRWSRPKEHR-UHFFFAOYSA-NSMILESCC(C)C1=C(OCC2=NCCN2)C=C(C)C=C1

What you can answer from here — as of June 12, 2020

1Drug interactionStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 2 drug categories

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Tymazoline, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.